CG
WVE icon

Cutler Group’s Wave Life Sciences WVE Stock Holding History

Cutler Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-11,000
Closed -$62K – 4979
2020
Q1 		$62K Sell
11,000
-9,100
-45% -$77.5K ﹤0.01% 1604
2019
Q4 		$102K Buy
+20,100
New +$493K 0.01% 1193
2019
Q3 		– Sell
-3,000
Closed -$42K – 4804
2019
Q2 		$42K Hold
3,000
– – ﹤0.01% 1679
2019
Q1 		$19K Buy
+3,000
New +$122K ﹤0.01% 2103

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Cutler Group's WVE Position: Q1 2021 in Review

Cutler Group sold out of Wave Life Sciences (WVE) in Q1 2021, closing a stake of 100 shares.

Cutler Group first reported a position in WVE in Q3 2018 and held it in 7 quarters. The position peaked at $200K in Q2 2019. 102 funds tracked by Wall St. Rank hold WVE as of Q1 2021.

  • Cutler Group reported no remaining Wave Life Sciences position as of Q1 2021 after selling out during the quarter.
  • Cutler Group sold 100 Wave Life Sciences shares in Q1 2021.
  • Cutler Group first reported a position in Wave Life Sciences in Q3 2018 and held it in 7 quarters.
  • Cutler Group's Wave Life Sciences position peaked at $200K in Q2 2019.
  • 102 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2021.

Based on Cutler Group's 13F filing for Q1 2021, filed 26 Apr 2021.